Quick Answer
Foghorn Therapeutics Inc. reported Shares Outstanding of 56.66 million shares for fiscal year 2025.
Foghorn Therapeutics Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 56.66M | +1.9% |
| 2024 | 55.59M | +31.5% |
| 2023 | 42.28M | +1.1% |
| 2022 | 41.80M | +1.2% |
| 2021 | 41.30M | +12.3% |
| 2020 | 36.79M | +655.3% |
| 2019 | 4.87M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 56.54M | +1.7% | +1.3% |
| June 30, 2025 | 55.80M | +0.9% | +0.1% |
| March 31, 2025 | 55.72M | +30.8% | +0.2% |
| December 31, 2024 | 55.59M | +31.5% | +0.0% |
| September 30, 2024 | 55.59M | +31.7% | +0.5% |
| June 30, 2024 | 55.33M | +32.2% | +29.9% |
| March 31, 2024 | 42.59M | +1.8% | +0.7% |
| December 31, 2023 | 42.28M | +1.1% | +0.2% |
- Foghorn Therapeutics Inc. showed an increase of +1.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Foghorn Therapeutics Inc.’s shares outstanding has grown by 1063.2% (from 4.87 million shares to 56.66 million shares).
- The most recent figure is from Foghorn Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: